BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7608283)

  • 1. Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade.
    Fazio S; Biondi B; Carella C; Sabatini D; Cittadini A; Panza N; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2222-6. PubMed ID: 7608283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.
    Biondi B; Fazio S; Carella C; Sabatini D; Amato G; Cittadini A; Bellastella A; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1994 May; 78(5):1028-33. PubMed ID: 8175955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study.
    Smit JW; Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bleeker GB; Holman ER; van der Wall EE; Romijn JA; Bax JJ
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6041-7. PubMed ID: 16131580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine.
    Biondi B; Fazio S; Cuocolo A; Sabatini D; Nicolai E; Lombardi G; Salvatore M; Saccà L
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4224-8. PubMed ID: 8954019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of isolated left ventricular diastolic dysfunction in high-risk differentiated thyroid carcinoma patients on TSH-suppressive therapy.
    Taillard V; Sardinoux M; Oudot C; Fesler P; Rugale C; Raingeard I; Renard E; Ribstein J; du Cailar G
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):709-14. PubMed ID: 21645022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.
    Biondi B; Fazio S; Carella C; Amato G; Cittadini A; Lupoli G; Saccà L; Bellastella A; Lombardi G
    J Clin Endocrinol Metab; 1993 Aug; 77(2):334-8. PubMed ID: 8345037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term overt hypothyroidism induces discrete diastolic dysfunction in patients treated for differentiated thyroid carcinoma.
    Hoftijzer HC; Bax JJ; Heemstra KA; Bleeker GB; Delgado V; van der Klaauw AA; Romijn JA; Smit JW; Corssmit EP
    Eur J Clin Invest; 2009 Mar; 39(3):204-10. PubMed ID: 19260950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of bisoprolol in prevention of heart left ventricular hypertrophy in patients with long term L-thyroxin suppressive therapy, after the operation of differentiated thyroid carcinoma].
    Matuszewska G; Marek B; Kajdaniuk D; Przywara-Chowaniec B; Jarzab J; Jarzab B
    Endokrynol Pol; 2007; 58(5):384-96. PubMed ID: 18058733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term thyroid hormone suppressive treatment on the cardiac functions.
    Khanna CM; Dubey YS; Shankar R; Kaur G
    Indian Heart J; 1997; 49(3):289-92. PubMed ID: 9291652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C; Golia F; Vignali E; Pinchera A
    J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
    Marcocci C; Golia F; Bruno-Bossio G; Vignali E; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function].
    Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L
    Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism.
    Biondi B; Fazio S; Palmieri EA; Carella C; Panza N; Cittadini A; Bonè F; Lombardi G; Saccà L
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2064-7. PubMed ID: 10372711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction.
    Gullu S; Altuntas F; Dincer I; Erol C; Kamel N
    Eur J Endocrinol; 2004 May; 150(5):655-61. PubMed ID: 15132721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyroxine therapy on right ventricular systolic and diastolic function in patients with subclinical hypothyroidism: a study by pulsed wave tissue Doppler imaging.
    Turhan S; Tulunay C; Ozduman Cin M; Gursoy A; Kilickap M; Dincer I; Candemir B; Gullu S; Erol C
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3490-3. PubMed ID: 16822817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine.
    Shapiro LE; Sievert R; Ong L; Ocampo EL; Chance RA; Lee M; Nanna M; Ferrick K; Surks MI
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2592-5. PubMed ID: 9253339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
    Vogt M; Kreutz KU; Motz W; Strauer BE
    Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring.
    Mercuro G; Panzuto MG; Bina A; Leo M; Cabula R; Petrini L; Pigliaru F; Mariotti S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):159-64. PubMed ID: 10634380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
    Botella-Carretero JI; Gómez-Bueno M; Barrios V; Caballero C; García-Robles R; Sancho J; Escobar-Morreale HF
    Endocr Relat Cancer; 2004 Jun; 11(2):345-56. PubMed ID: 15163309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.